Literature DB >> 35967906

Improving antibody thermostability based on statistical analysis of sequence and structural consensus data.

Lei Jia1, Mani Jain1, Yaxiong Sun1.   

Abstract

Background: The use of Monoclonal Antibodies (MAbs) as therapeutics has been increasing over the past 30 years due to their high specificity and strong affinity toward the target. One of the major challenges toward their use as drugs is their low thermostability, which impacts both efficacy as well as manufacturing and delivery.
Methods: To aid the design of thermally more stable mutants, consensus sequence-based method has been widely used. These methods typically have a success rate of about 50% with maximum melting temperature increment ranging from 10 to 32°C. To improve the prediction performance, we have developed a new and fast MAbs specific method by adding a 3D structural layer to the consensus sequence method. This is done by analyzing the close-by residue pairs which are conserved in >800 MAbs' 3D structures.
Results: Combining consensus sequence and structural residue pair covariance methods, we developed an in-house application for predicting human MAb thermostability to guide protein engineers to design stable molecules. Major advantage of this structural level assessment is in significantly reducing the false positives by almost half from the consensus sequence method alone. This application has shown success in designing MAb engineering panels in multiple biologics programs. Conclusions: Our data science-based method shows impacts in Mab engineering.
© The Author(s) 2022. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  consensus; covariance; monoclonal antibody; structure; thermostability

Year:  2022        PMID: 35967906      PMCID: PMC9372885          DOI: 10.1093/abt/tbac017

Source DB:  PubMed          Journal:  Antib Ther        ISSN: 2516-4236


  21 in total

1.  IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures.

Authors:  Manuel Ruiz; Marie-Paule Lefranc
Journal:  Immunogenetics       Date:  2002-01-30       Impact factor: 2.846

2.  Detection and prevention of protein aggregation before, during, and after purification.

Authors:  Sarah E Bondos; Alicia Bicknell
Journal:  Anal Biochem       Date:  2003-05-15       Impact factor: 3.365

3.  Consensus-based engineering of protein stability: from intrabodies to thermostable enzymes.

Authors:  Boris Steipe
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

Review 4.  Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering.

Authors:  Stefan Ewert; Annemarie Honegger; Andreas Plückthun
Journal:  Methods       Date:  2004-10       Impact factor: 3.608

5.  Improving the stability of an antibody variable fragment by a combination of knowledge-based approaches: validation and mechanisms.

Authors:  Elodie Monsellier; Hugues Bedouelle
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

Review 6.  Principles, approaches, and challenges for predicting protein aggregation rates and shelf life.

Authors:  William F Weiss; Teresa M Young; Christopher J Roberts
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

7.  An integrated approach to extreme thermostabilization and affinity maturation of an antibody.

Authors:  Audrey D McConnell; Vladimir Spasojevich; John L Macomber; Irina P Krapf; Andy Chen; Joseph C Sheffer; Ashley Berkebile; Robert A Horlick; Steven Neben; David J King; Peter M Bowers
Journal:  Protein Eng Des Sel       Date:  2012-11-19       Impact factor: 1.650

8.  Consensus engineering of sucrose phosphorylase: the outcome reflects the sequence input.

Authors:  Dirk Aerts; Tom Verhaeghe; Henk-Jan Joosten; Gert Vriend; Wim Soetaert; Tom Desmet
Journal:  Biotechnol Bioeng       Date:  2013-05-07       Impact factor: 4.530

9.  Designing human consensus antibodies with minimal positional templates.

Authors:  J R Couto; R B Christian; J A Peterson; R L Ceriani
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

10.  Development of scoring functions for antibody sequence assessment and optimization.

Authors:  Daniel Seeliger
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.